InvestorsHub Logo
Followers 8
Posts 3255
Boards Moderated 0
Alias Born 12/29/2004

Re: Fourthquarter post# 831

Tuesday, 02/15/2011 11:07:21 AM

Tuesday, February 15, 2011 11:07:21 AM

Post# of 903

Clinical Data acquisition activity may be "heating up", says Wedbush
Clinical Data's CEO withdrew from the BIO CEO & Investor conference. Wedbush believes this may suggest acquisition activity may be "heating up" and notes management's openness to a "change in control" discussed on a recent conference call. The firm raised Clinical Data's price target to $42 from $28 and reiterates its